Open AccessIdentifying enhancement-based staging markers on baseline MRI in patients with colorectal cancer liver metastases undergoing intra-arterial tumor therapy
Author(s) -
Mansur A. Ghani,
Arash Fereydooni,
Evan Chen,
Brian Letzen,
Fabian M. Laage Gaupp,
Nariman Nezami,
Yanhong Deng,
Geliang Gan,
Vinayak Thakur,
Ming De Lin,
Xenophon Papademetris,
Rüdiger Schernthaner,
Steffen Huber,
Julius Chapiro,
Kelvin Hong,
Christos Georgiades
Publication year - 2021
Publication title -
european radiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.606
H-Index - 149
eISSN - 1432-1084
pISSN - 0938-7994
DOI - 10.1007/s00330-021-08058-7
Subject(s) - medicine , colorectal cancer , proportional hazards model , hazard ratio , liver cancer , survival analysis , nuclear medicine , cancer , radiology , oncology , urology , gastroenterology , confidence interval
To determine if three-dimensional whole liver and baseline tumor enhancement features on MRI can serve as staging biomarkers and help predict survival of patients with colorectal cancer liver metastases (CRCLM) more accurately than one-dimensional and non-enhancement-based features.